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Background: Perineural invasion is a common path for cholangiocarcinoma (CCA) metastasis, and it is highly
correlated with postoperative recurrence and poor prognosis. It is often an early event in a disease that is
commonly diagnosed in advanced stages, and thus it could offer a timely therapeutic and diagnostic target if
better understood. This article systematically reviews the progress of CCA neural invasion-related molecules.
Methods: Studies were identified by searching MEDLINE and PubMed databases for articles from January 1990 to
December 2009, using the keywords “cholangiocarcinoma,”“ perineural invasion,”“ nerve growth factor"(NGF),
“neural cell adhesion molecule” (NCAM), “matrix metalloproteinase"(MMP), “neurotransmitter,”“ acetylcholine” (Ach),
and “transforming growth factor” (TGF).” Additional papers and book chapters were identified by a manual search
of references from the key articles.
Results: From above we found that the molecules NGF, NCAM, MMP, Ach and TGF may have prognostic
significance in, and offer clues to the mechanism of CCA neural invasion.
Conclusions: Cholangiocarcinoma’s increasing worldwide incidence is especially poignant in view of both the
lacking effective therapies, and the fact that it is commonly diagnosed in advanced stages. As CCA neural invasion
often appears early, more complete characterization of its molecular pathology could lead to the identification of
targets for the diagnosis and therapy of this devastating malignancy.
Review
Cholangiocarcinoma (CCA) is a malignant tumor origi-
nating from biliary tract epithelial cells. Among primary
liver tumors, CCA incidence is only less than that of
liver cancer[1,2], and it is becoming the most common
hepatic tumor-induced death[3].
Due to its difficulty of diagnosis and high fatality rate,
cholangiocarcinoma is extremely destructive, currently
surgery is the only therapeutic mode offering a cure.
Moreover, the post-resection recurrence rate is extremely
high and the five-year survival rate is only 5%, at the
same time, this survival rate had not vastly improved in
past three decades[4]. In recent years, its worldwide mor-
bidity and mortality have increased rapidly. Invasion deli-
tescence, insufficient markers for early diagnosis marker,
insensitivity to regular radio- and chemotherapy–these
are all causes of poor prognoses of CCA patients[5,6].
Cholangiocarcinoma via perineural invasion is an
extremely part during its genesis and development
especially the early period. Perineural invasion (PNI)
involves tumor cells surrounding nerve fibers, and
entering the perineurium, spreading local infiltration
and metastasis. The peripheral nerve is covered by
three layers of membrane–the adventitia, perineurium
and endomembrane. Carcinoma cells found in the
perineurium are indicative of neural invasion[7]; the
proportion of perineural invasion in CCA is around
85-88%. While the tumor perineural invasion is gener-
ated in cholangiocarcinoma, it indicated that the
tumor is not only localized in the primary organ, but
metastasis in distance or the tumor cell residue stays
in abdominal cavity; furthermore, it is quite hard to
radical cure by the operation and the clinical prognosis
is extremely bad[8]. A study of 26 cases of neural inva-
sion (NI) of CCA in the porta hepatis region revealed
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val rates of CCA patients without NI are clearly longer
than those with NI, which indicates that the neural
invasion is a common pathology for CCA–one that is
highly correlated with postoperative recurrence and
poor prognosis[9]. Some prognosis of perineural inva-
sion was evidently less than that of non invasion
patients, especially the tumor has not invaded into
plasma membrane, nevertheless, while accompanied by
tumor perineural invasion, the prognosis was even
worse[10]. Therefore, PNI and postoperative recur-
rence rate are closely related. Consequently, if the
mechanism of CCA PNI could be understood and
interrupted in early-stage CCA, the prognosis of CCA
patients could be greatly improved.
Anatomic Foundation of Cholangiocarcinoma PNI
In the human hepatoduodenal ligament, the pampini-
form nerve plexus can be clearly seen, and it can be
classified into hepatic anteplex and hepatic metaplex.
The hepatic anteplex is composed of the left and right
celiac ganglia and left vagus nervous ramification, which
includes the cystic duct, gallbladder and cholo-pancrea-
tic common bile duct ramification. The scabbard is
formed around the hepatic artery, and leads, via the
hepatic artery, into the liver. The hepatic metaplex is
composed of the right celiac ganglia and right vagus
nerve ramification, which are mainly distributed along
the extrahepatic bile duct and portal vein; some of its
ramification links with the anteplex nervous ramifica-
tion. The sensory fibers of the right phrenic nerve are
distributed in the coronary ligament, the falciform liga-
ment of the liver, and the vicinal liver capsule[11], while
part of the fibers combined with the liver ante- and
metaplex, along with the fibers of the hepatic plexus,
and distributes into the exterior and interior biliary sys-
tem of the liver. The whole liver is controlled by the
sympathetic and parasympathetic nerves. They are dis-
tributed in the hepatic artery, vena portae hepatic, liver
interior and extrahepatic bile duct; the sympathetic
nerve originates from celiac ganglia, while the parasym-
pathetic nerve comes from the vagus nerve[12]. There-
fore, the biliary system is typical of organs with
extremely fundamental autonomic nerves, which could
be controlled by an extensive neural system. The nerve
terminal is partially removed through the porta hepatic
hemal tube structure, surrounded by the bile duct and
blood vessel. The bile duct is one of the most important
components of the liver, which is also the channel of
choleresis and excretion. As the nerve terminal acts on
the liver hemal tube system, the patho- and physiologi-
cal functions of bile duct epithelium are inevitably
affected, providing the anatomic foundation for CCA
metastasis via PNI.
Cholangiocarcinoma PNI as independent metastasis
pathway
Among gastrointestinal malignancies, PNI is often seen in
pancreatic and biliary system cancers, and occasionally in
rectal cancer. It is a local diffusion mode for tumors, and
it plays a critical role in prognosis. Current study shows
tumor perineural invasion to be uncorrelated with
patient’s age or sex as well as whether or not tumor metas-
tasis in distant (including liver metastasis or abdominal
cavity, peritoneum metastasis). However, it is highly corre-
lated with tumor volume, location, depth of invasiveness,
angiogenesis and lymph node involvement[13]. After CCA
saturated the whole cliff, nearly hundred percent of tumor
occurred nerve infiltration, which was far higher than lym-
phatic metastasis and circulatory metastasis.
Physically, the biliary system is close to both the per-
ipheral nerve plexus and the coelial plexus, which proxi-
mity may facilitate peripheral nerve invasion by biliary
tumors. Some reports consider that the biliary system is
rich in autonomic nerves, which may also facilitate peri-
neural invasion[14]. However, neither of these facts
completely explains the specific mechanism of tumor
cells entering into nerve tissue. Recent investigation has
indicated that the relationship between PNI occurrence
and the distance between tumor and nerve plexus was
not close. Secondly, the tumor cells invade nerves via
the perineural lymphatic vessel. Previous studies consid-
ered that tumors invade nerves along the “path of least
resistance,” or are transported along blood and lympha-
tic pathways[15,16]. However, in rectal cancer, especially
distal rectal cancer, although these tumors are close to
the sacral nerve plexus, one study found that the rate of
perineural invasion is rather low, only 9.9-34.9% [17];
this investigation also indicated that nervous invasion
was not correlated with the location of carcinoma swel-
ling, volume, histology category, at even the status of
lymphatic metastasis. Tumors had previously been
thought to invade nerve through the lymphatic pathway
in the nerve or perineurium. However, an investigation
found that about 34% of pancreatic carcinoma patients
with NI were without lymphatic metastasis, while 75%
of such patients without any NI appeared to have lym-
phatic metastasis. Therefore, it is considered that the
possibility of the patients with widespread lymphatic
metastasis who emerged peripancreatic nervous invasion
was quite high. However, peripancreatic nervous inva-
sion is not completely determined by lymphatic path-
way. Another report found no perineural lymphatic
vessel, by either electron microscope or light micro-
scope; however, they found that nerves in the perineur-
ium can be separated from their peripheral connective
tissue, generating low-resistance, slit-like interspaces in
the nerve periphery, which are easily invaded by tumor
cells[18], which suggests that if a tumor came through
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could be a focus of jump infection with lymphatic
metastasis characteristics. Moreover, the tumor will not
offend the nerve for a wrap. If tumor cells invade nerves
through the low-resistance perineural layer, then the
insufficiency of the leap focus of infection was bound to
invade the nerve for a wrap. So the femoral nerve of the
rats and Walk2er256 tumor cell were incubated together
by Rodin, one week later, the tumor cells completely
wrapped the nerve and without any leap focus of infec-
tion. Recent progressive investigation also found that
the perineurium was available in three different weak
positions. Such as entrance and exit of blood vessel,
invasion court of reticular fiber. The pancreatic cancer
invaded into perineurium through its weak part, then
spread and diffused along the perineural interspace to
the outside of the perineurium, forming a new metasta-
sis, which was not the previous presumed lymphatic dif-
fusion pathway. Meanwhile, from the research on
esophageal carcinoma, a report also revealed that the
tumor cell infiltrated periphery nerve was not accorded
with cell of lymphatic glands[19]. Consequently, it was
impossible that the tumor cell invaded peripheral nerve
tissue through peripheral lymphatic vessels, nor was any
direct relationship involved in the tumor peripheral
nerve infiltration and lymphatic metastasis.
Another study reestablished modes of CCA nervous
invasion and metastasis using computer-assisted three-
dimensional (3D) reconstruction. The computer-formed
CCA 3D stereoscopic pictures, showing the spatial rela-
tionships between CCA and nerves, lymphatic vessels and
blood vessels, revealed that small vessels, lymphatic vessel
and nerve fibers all existed in the tumor periphery, offer-
ing an anatomic foundation for CCA nerve invasion. In
particular, the 3D CCA model showed that tumor cells in
the nervous peripheral interspace are able to survive inde-
pendently, as they are in small blood and lymphatic ves-
sels[20]. All the above investigations indicate that tumor
perineural invasion is actually a type of tumor local growth
pattern. The perineural interspace invasion was the fifth
dependent metastasis pathway to be discovered (preceded-
after abdominal tumor direct invasion metastasis, implan-
tation metastasis, lymphatic, and blood route metastasis).
In PNI, leap metastasis is possible; e.g., CCA could metas-
tasize into liver via the neural interspace.
Progress of Cholangiocarcinoma PNI-related
Molecules
Effect of NGF on CCA PNI
Nerve growth factor (NGF) was the first discovered
member of the neurotrophic factor family; this family is
widely expressed in tumor tissues, and is involved in
tumorigenesis and tumor growth. Receptors for NGF
include two different proteins: TrkA, which has high
affinity, and is a Tyr protein kinase receptor encoded by
the proto-oncogene trk; and NGF receptor p75, which
has low affinity. The protein p75 is a glycoprotein
mainly expressed in NGF-reactive cells; it is involved
with apoptosis and cell migration[21]. One report, using
the bile duct ligation model, showed NGF and its recep-
tor TrkA to be expressed in common bile duct epithe-
lium[22] They also discovered the proliferative response
of fibroblase, elastic fiber in bile duct connective tissue,
accompanied by elevated expression of NGF and its
receptor TrkA. This indicates that NGF and TrkA both
play critical roles in the proliferation of connective tis-
s u ei nt h eb i l ed u c t .S o m ee x p erimental results proved
that NGF expressed in CCA could facilitate CCA cell
proliferation[23,24]; while NGF secreted by CCA cells
could facilitate autospecific proliferation, it might also
bind to TrkA receptors expressed in the perineurium,
which supplies an adaptive microenvironment and che-
mical tropisms for the growth of nerve cellular axons,
facilitating axon growth in the direction of the tumor
[25]. The expression of NGF and its receptors in a wide
range of tumor cells show its critical relationship with
tumor proliferation and invasion, especially in nerve tis-
sue. So its signal pathway was able to be used as the tar-
get for the early intervention and therapy.
Effect of Neural Cell Adhesion Molecules on CCA PNI
Neural cell adhesion molecules (NCAM) belong to the
adhesion molecule immunoglobulin family, which
belongs to IgG super family and mediates cellular adhe-
sion. NCAMs play critical navigation and docking roles
by binding to target cells during the growth and devel-
opment of the nervous system. NCAM is highly
expressed in peripheral nerve tissue. It has an ecotropic
relationship to nervous tissue and plays a critical role in
the genesis and metastasis of CCA[26]. Some researches
f o u n dt h a tN Ii sc o r r e l a t e dw i t hN C A Me x p r e s s i o n ,
indicating that NCAM molecules on the surface of
tumor cells might induce them to migrate and adhere to
nerve cells after the tumors breach their capsules[27]. In
particular, NCAM expression is highly correlated with
CCA PNI, and with CCA dedifferentiation. Moreover,
N C A Mw a ss h o w nt ob eas p e c i f i ci n d i c a t o rf o rb i l e
duct NI. A study of the relationship between the expres-
sion of NCAM and the anti-oncogene DPC4, and CCA
NI, showed that the NCAM expression rate in CCA
with NI was significantly higher than in CCA without
NI, indicating that NCAM is related to CCA NI and
might play a critical role in the nerve invasion process
[28]. NCAM expression rates generally increase with
CCA invasiveness, indicating a relationship between
NCAM expression and cancer cells’ ability to adhere to
nerve tissue, thus enabling nervous invasion. Recent evi-
dence indicates that activation of the proto-oncogene K-
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lation of PSA-NCAM on tumor cell surfaces. PSA-
NCAM could bind to N-cadherin, blocking N-cadherin
mediated cell adhesion, increasing pancreatic cancer cell
migration ability and facilitating tumor cell metastasis to
nerve tissue[29]. The above investigations all suggest that
NCAM levels are positively correlated to CCA NI, and
which might serve as indicators for prognosis in CCA.
Effect of Matrix Metalloproteinases on CCA PNI
Matrix metalloproteinases ( M M P s )a r eaf a m i l yo fz i n c
finger-dependent endogenous proteinases. Previous
investigation showed MMPs to be critical enzymes
which are able to decrease ECM, in addition, it was a
specific growth factor (for instance, ECM related growth
factor) hard to diffuse in the activation of ECM or hid-
den by matrix, so which that facilitate the tumor cells
through the basement membrane. MMPs are involved
in multiple cancer-related processes such as tumorigen-
esis, growth, migration, angiogenesis and anti-apoptotic
functions[30,31]. Some reports investigating the correla-
tion between S100, MMP-7 and CCA nerve invasion
have found that expression of MMP-7 in CCA tissue is
higher than in latero-carcinoma tissue; moreover, it
shows significant correlation with the tumor lymphatic
metastasis[32,33], Which indicates that MMP protein
might be involved in CCA oncogenesis, and its up-regu-
lation may facilitate CCA metastasis, and which further
suggests that activation of MMP-7 is a critical promot-
ing agent of CCA NI; high MMP-7 expression seems to
correlate with higher malignancy and less favorable
prognosis in CCA sufferers.
Reportedly, MMP-9 secretion is significantly enhanced
in CCA cells that invade nerve tissue; it has been sug-
gested that some component in peripheral nerves is able
to induce MMP-9 secretion in CCA cells[34]. A novel
signaling pathway of MMP-9 up-regulation in CCA cells
has been proposed that features TNF-alpha-induced
activation of COX-2 and PGE2 via TNF-R1, could be
followed by up-regulation of MMP-9 via the PGE2
(EP2/4) receptor[35]. Recent reports indicate that cor-
pora mammillaria CCA, which is less prone to PNI than
most CCA, is characterized by comparatively low
expression of MT-MMPs, as well as better prognoses
[36]. For this reason, MMPs expression is a critical
reference index for assessing CCA bionomics and the
evaluation of prognosis.
Effect of Neurotransmitters on CCA PNI
Sympathetic nervous system
The first clue to the role of the sympathetic nervous sys-
tem in regulating CCA growth was the discovery that the
a-2A, a-2B, and a-2C adrenergic receptor subtypes were
all expressed in the CCA cell lines Mz-ChA-1 and TFK1.
In a further investigation, after applying a-2 adrenergic
receptor agonist, uK14, they found that uK14 could inhi-
bit the growth of CCA by stimulating tumor cells[37].
Recent evidence revealed that expressions of a-1 adre-
nergic receptor and b-2 in CCA cells that generate per-
ipheral nervous metastasis and lymphatic metastasis were
significantly higher than in non-metastatic CCA cells[38].
In addition, NE could facilitate the cell proliferation and
metastasis of CCA, while applying the relative receptor
blocker might significantly inhibit this kind of promotion.
The CCA environment is regionally rich in sympathetic
nerve fibers, offering the sort of intercommunication
conducive to perineural invasion. This mechanism needs
some further investigations.
Parasympathetic Nervous System
The parasympathetic nervous system (PSNS) plays a cri-
tical role in the oncogenesis of bile duct cells. The main
neurotransmitter secreted by PSNS is acetylcholine
(Ach), which has been shown to mediate cellular trans-
formation and differentiation[39], and might play a criti-
cal role in normal cellular proliferation, differentiation,
transformation, as well as tumorigenesis etc[40]. Multi-
ple experiments have confirmed Ach expression in var-
ious tumors, notably metastatic small-cell lung cancer
[41]. It appears that Ach is involved in diseases far
beyond its effects as a neurotransmitter. Previous evi-
dence showed that the muscarinic acetylcholine receptor
is expressed in the gallbladder cancer cell line Mz-ChA-
1; while cultivating the muscarinic AchR receptor ago-
nist carbonic acid bilineurin with the gallbladder cancer
cells, the activation of the IP3 signal and enhancement
of calcium level were observed[42]. Other research
assumed that, with the stimulation of different mole-
cules, IP3 and calcium level played critical roles in the
inhibition of CCA growth. However, muscarinic AchR is
directly activated by other molecules; bile acid has been
found to stimulate M3 AchR, a reaction mediated by
EGFR, thus stimulating the proliferation of colon carci-
noma cells[43]. This kind of effect could induce the
phosphorylation of p10RSK via the Ca/MEK/MAPK
dependent pathway. Some reports showed that Ach
could up-regulate expression of DNA repairase PRX1
and promote cell differentiation in lung cancer, for
which a possible correlation between Ach and cancer
cell transformation has been indicated[44,45]. However,
the role of PSNS with regard to CCA-PNI has currently
not been elucidated; considering the critical regulatory
effect of the vagus nerve on the biliary system, it is likely
that the PSNS plays a regulating role in CCA-PNI.
Effect of TGF on CCA PNI
In 1980s, investigators found that some tumor cells
could produce a polypeptide, transforming growth factor
(TGF), which could stimulate inactive growth cells into
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types, TGF-a and TGF-b. Previous investigation indi-
cated that TGF-b1w a sh i g h l ye x p r e s s e di nm o s tt u m o r
cells, and that over-expression of TGF-b in tumor was
associated with tumor growth, metastasis, angiogenesis,
and dedifferentiation[46]. High expression of TGF-b was
also detected in colorectal cancer, gastric cancer, breast
carcinoma, prostatic carcinoma, bladder carcinoma and
endometrial cancer, and which was associated with
tumor succession, growth and metastasis[47,48]. Tumor
cell metastasis is a kind of reversible epithelium-to-
mesochymal transformation (EMT) in vivo, this was
possibly a transient differentiation event, in the anaphase
of tumorigenesis, TGF-b directly affected the tumor cell
and accelerated the growth of tumor. Then the activa-
tion of Akt/PKB was induced by TGF-b via RhoA and
PI-3K pathway, subsequently, Z0-1 was activated, cell
morphous altered, the cell-cell junction changed, and
finally the tumor metastasis was induced.
Zhang et al found that[49], with the enhancement of
CCA clinical stage, the expression of TGF-b1 increased,
indicating that TGF-b1 could be involved in the genesis,
growth and clinical scale of CCA, as well as perineural
lymphatic invasion. Lu et al. also reported that TGF-b1
expression increased with tumor grade, suggesting that
TGF-b1 not only suppresses growth but can also sup-
press immunity[50]. In HCCs, TGF-b1 expression is
enhanced (compared to adjacent tissues), while TGF-
bR2 expression is weakened, due to lower TGF-bR2
expression in those HCC cells that can escape from the
inhibitory effects of TGF-b1. Some initiation and devel-
opment of HCC may be caused by this process. In all
MMTV-PyVmT tumor cells, the inhibition of TGF-b
could significantly depress basal cell mobility, survival
rate, anchoring dependent growth, tumorigenesis and
metastasis, indicating that variations in metastasis are
controlled by auto-regulation of epithelial cells[51]. Cur-
rent reports show that the overexpression of TGF-a is
common in gastrointestinal tumors. otherwise, generous
animal studies confirmed that while the carcinomatous
change was occurred, three different mode of action
such as autocrine, paracrine and juxtacrine were all
available, and autocrine circulation was the main mode
for TGF-a. Zhuang et al[49]. showed that overexpres-
sion of TGF-a w a sc o m m o ni nC C Ac e l l s ,s u g g e s t i n ga
mechanism in which cytogenic TGF-a first binds to
EGFR, which in turn activates tyrosine protein kinase
(Tyr-PK) [52]. In fact, EGFR-activated Tyr-PK could
facilitate DNA synthesis and cause cell proliferation and
differentiation. Moreover, with the collective effect of
other factors, a cell starting malignant transformation
could secrete TGF-a, inducing hyperexpression of TGF-
a and EGFR, and causing uncontrolled growth [53].
Either of these mutual effects could generate signals that
facilitate cancer cell proliferation and growth, stimulat-
ing its diffusion and generating nervous invasion. Thus,
TGF plays a critical role in the proliferation of digestive
system tumors and NI, especially in CCA.
The proliferation of CCA through perineural invasion
is a pathological process with multiple factors and pro-
cesses. We aim to focus on its possible mechanisms,
and search for novel methods and targets to prevent
perineural invasion in early-phase CCA.
Conclusions
Cholangiocarcinoma is difficult to diagnose; conse-
quently it is commonly identified in its advanced and
least treatable stages. However, CCA neural invasion
often occurs early on, suggesting that more complete
characterization of this pathway could help identify
more timely therapeutic and diagnostic targets for this
devastating malignancy.
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